{"name":"Geode Therapeutics Inc.","slug":"geode-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPNDhDYk9Bd0pONWtEaXBydzhKcS1aMWtxcjF2QkpnSUxYMzJzOVRTdUYwaGpraDh1cmJCTGVqNzJRVFlFenRUczJfb1ZZRzlOLVFOa2FGcXJVQmZYU1lHbExPM2VOVmJuWWM4Q1JDSlQ4VnhwaklQdEphMlM0djJPY1pnMUdZV014YzVJUFdMR09mbmZCMDJfSzJjTjU4aXJvWVd3SlFOZEtYUQ?oc=5","date":"2026-04-02","type":"deal","source":"Defense World","summary":"MiNK Therapeutics’ (INKT) “Buy” Rating Reaffirmed at HC Wainwright - Defense World","headline":"MiNK Therapeutics’ (INKT) “Buy” Rating Reaffirmed at HC Wainwright","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPSERNUVA1MGpDdk9memlUT3oxc3E4TTBBWVYtWmhhWkNnX2pTTGg1WjdieWJWVE13WW9sVjN3d2l5QWFIYVhqSzVPTGF4bm96azczbU9DN09sNmVsNFNvVS1TX2Q5YU5fcHc4ZWpkTExmei0xc1JzNFBGUzVhaHlSQ2tjekRQcmJQa3FqbGNkMHZRQnZuMjJzX1pPLWp0X0hUREJMVktMelNTVHF6T0RqcVZkLWl1bXkxdjNZSEphWQ?oc=5","date":"2026-03-31","type":"pipeline","source":"MarketBeat","summary":"Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Down 14.4% in March - MarketBeat","headline":"Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Down 14.4% in March","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNMXZHMjctVGVEajFPc25wWHEyMjdaeUkyRGdBX3JlLVhWVVdaaktranduTks5S19TOUh6MC1XOG9tczlYTUJkZ1Z3NF9KVlBuNWtldXlZUERPd3Zaa3ZrNnR1VWlwenJ5VXZhWW82emdGal9wazR3ZXdlQ2VVb3NBN295aElFWlVaSkJPSWVINzNDdTctR01CQ0plUWdiMGRlSGlKSzEyTExvdVRaN0pGVHRkdTJJOWlibDV2cHNyYnhOWnQ5Vk82TzlBQQ?oc=5","date":"2026-03-15","type":"deal","source":"MarketBeat","summary":"Cannell Capital LLC Buys 67,230 Shares of Eton Pharmaceuticals, Inc. $ETON - MarketBeat","headline":"Cannell Capital LLC Buys 67,230 Shares of Eton Pharmaceuticals, Inc. $ETON","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNV1EtdW51SHhhQnBFdXRkd0dVQnFoN0Z6V3FucXJkMER3Qkc1a3pBQlV4MWI2Skp3WDZvRzBZbWo1SDZ4M3ktdEJFdzl4aTd5Y19kY0Z6a3R5ellkNjFEczlwSjJHWXI3RUt2a0FiaE5DM01vU3A5WkxEczVHWHdsTHhIb2dpSXNIYml2YWhPZHhaQmY3UTlWcEZyOUpOZHdFT3c?oc=5","date":"2024-06-13","type":"pipeline","source":"BioWorld News","summary":"China’s AI-powered Quantumpharm raises $126M in Hong Kong IPO - BioWorld News","headline":"China’s AI-powered Quantumpharm raises $126M in Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNLVNGa21oNzJuUFhCRm5LMTlsVGZLell3Rmpnb1FhUTVaTUZRM0t1RFoyd1RMQWNZWG1SQjU4SVdSY0ZiLWtiYXcxV3RDUEFsMGNWUUZZd3pUU1o4b25uS1Q1WG9weTB2WHNJX0VROTJoZTB0OWdtX2VUMXJMT1ZXTktLNDRoS1lkd2ZTRDktdVAtUUF1OXNmZ3JHRmgtMVZlVl9tb3RtNWcxRGhtaFlQdjB6N0U?oc=5","date":"2021-04-15","type":"pipeline","source":"Fierce Biotech","summary":"Tectonic Therapeutic banks $80M to shift GPCR drug discovery toward biologics - Fierce Biotech","headline":"Tectonic Therapeutic banks $80M to shift GPCR drug discovery toward biologics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9jaWExNWVmblBaZWZVNndkdm9wZFNHenpua3NTWXBtWllNeGo2Sm1qeFlHby1jc19YWWlvemNqbEYzYkNQanZWR2QwZzhZaVRob0pSbUJYNmRzQk9UTl91VVhEQzlMVmEwMWlzUnVJZUFWMzE2N2YyanF3?oc=5","date":"2018-11-02","type":"pipeline","source":"MarketBeat","summary":"Tonix Pharmaceuticals (TNXP) Institutional Ownership 2026 - MarketBeat","headline":"Tonix Pharmaceuticals (TNXP) Institutional Ownership 2026","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}